title: On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.
abstract: BACKGROUND
  A study conducted in 1983 to identify and rank the symptoms experienced by patients receiving cancer chemotherapy reported that vomiting and nausea were the most important symptoms experienced. With the advent of new antiemetic regimens and changes in cancer chemotherapy, it was anticipated that changes may have occurred in patient perception of symptoms. The study was therefore repeated in 1993.
  
  
  METHODS
  One hundred and fifty-five cancer patients receiving chemotherapy at a large urban teaching hospital participated in the study. Patients selected from cards listing symptoms all those experienced and the five most troublesome.
  
  
  RESULTS
  Patients reported experiencing an average of 20 symptoms (13 physical and 7 psychosocial). Nausea was reported as the most severe symptom followed by tiredness and loss of hair. Vomiting which was the most severe symptom in 1983, now ranked 5th. Differences were detected in the symptoms experienced and reported as most severe, between chemotherapy regimens, between older and younger patients and between males and females.
  
  
  CONCLUSIONS
  The results suggest a reduction in the severity of some symptoms experienced while receiving chemotherapy and a shift from concerns about physical to psychosocial issues.
authors.affiliation: Medical Psychology Unit, Royal Prince Alfred Hospital, NSW, Australia.
authors.forename: A M
authors.initials: AM
authors.lastname: Griffin
authors.forename: P N
authors.initials: PN
authors.lastname: Butow
authors.forename: A S
authors.initials: AS
authors.lastname: Coates
authors.forename: A M
authors.initials: AM
authors.lastname: Childs
authors.forename: P M
authors.initials: PM
authors.lastname: Ellis
authors.forename: S M
authors.initials: SM
authors.lastname: Dunn
authors.forename: M H
authors.initials: MH
authors.lastname: Tattersall
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001294:Attitude to Health; D005260:Female; D006801:Humans; D015994:Incidence; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D017678:Sex Distribution; D014839:Vomiting / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents